In 2026, Connecticut’s Public Health Committee considered Raised H.B. 5242, legislation that would require certain health care facilities to allow terminally ill qualifying patients to use their state authorized medical cannabis on site. Under current practice, many hospitals, nursing homes, and hospice facilities prohibit cannabis entirely, forcing eligible patients off established regimens and onto higher doses of opioids and other sedating medications at the end of life. Lawmakers should align facility policy with Connecticut’s existing medical cannabis program to ensure terminally ill patients retain access to medicine that works for them. D4DPR supports this evidence-based, patient-centered reform and looks forward to assisting Connecticut in advancing compassionate access policies that prioritize dignity, comfort, and connection at the end of life.